Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid Tumors — Stella

Home/Lymphocytes/Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid Tumors

View on ClinicalTrials.gov

Recruiting

Back to Lymphocytes trials

Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid Tumors

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Johns Hopkins All Children's Hospital, St. Petersburg, Florida

Key details

Phase

Early testing

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

Swim Across America, Benjamin Gilkey Fund

Enrollment target

~30 participants

Started

June 2025

Primary completion

December 2026

Age range

1 Year – 21 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.